Clinical trial

Change in the Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship

Name
HSD135
Description
The main objective of the study is to describe the antimicrobial resistance profile of E. coli isolated in patients from the community - defined as those with cultures collected within 48 hours of hospital admission - and admitted to the intensive care unit.
Trial arms
Trial start
2024-04-01
Estimated PCD
2024-07-01
Trial end
2024-10-01
Status
Not yet recruiting
Treatment
Escherichia coli ESBL
To evaluate the change in the resistance profile of infections of community origin caused by Escherichia coli, isolated from any culture material in patients admitted to the intensive care unit of a tertiary hospital.
Size
200
Primary endpoint
Prevalence of Escherichia coli resistance
24 months
Eligibility criteria
Inclusion Criteria: * All 18 years and old patients admitted to the ICU * Positive cultures for E. coli * Any sample collected within 48 hours of hospital admission Exclusion Criteria: * Lack of necessary data
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'RETROSPECTIVE'}, 'enrollmentInfo': {'count': 200, 'type': 'ESTIMATED'}}
Updated at
2024-03-12

1 organization

1 product

1 indication